Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Paige A. Taylor Image

      Paige A. Taylor, PH.D.

      Department of Radiation Physics, Division of Radiation Oncology

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Radiation Physics Outreach, UT MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Regular Faculty Member, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX

      Assistant Professor, Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Medical Physics Graduate Program Faculty, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2023University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas, US, Medical Physics, Ph.D
      2011University of Texas MD Anderson Cancer Center, Graduate School of Biomedical Sciences, Houston, Texas, US, Medical Physics, M.S
      2009Santa Clara University, Santa Clara, California, US, Physics, BS

      Licenses & Certifications

      2015Texas Medical Board
      2015The American Board of Radiology, Therapeutic Medical Physics

      Experience & Service

      Faculty Academic Appointments

      Senior Medical Physicist, Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2024

      Associate Member of Graduate Faculty, Graduate School of Biomedical Sciences, Houston, TX, 2015 - 2024

      Medical Physics Program Faculty Associate, Graduate School of Biomedical Sciences, Houston, TX, 2012 - 2018

      Instructor, Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2011 - 2012

      Medical Physicist, Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2011 - 2018

      Instructor, Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2010 - 2011

      Summer Research Associate, Radiation Medicine, Oregon Health & Sciences University, Portland, OR, 2008 - 2009

      Administrative Appointments/Responsibilities

      Supervisor, Imaging Radiation Oncology Core - Houston IT Group, Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present

      Intramural Institutional Committee Activities

      Member, Medical Physics Graduate Program Steering Committee, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, 2024 - Present

      Chair, Medical Physics Graduate Program Admissions Committee, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, 2024 - Present

      Editorial Activities

      Associate Editor, International journal of particle therapy, 2025 - Present

      Guest Associate Editor, Frontiers in oncology, 2025 - 2026

      Honors & Awards

      2025phiRO Young Researcher Awards Shortlist, ESTRO
      2025Top 5% of ESTRO 2025 submitted abstracts, ESTRO
      2024Fellow, American Association of Physicists in Medicine
      2013HDR Brachytherapy Scholarship Award, American Brachytherapy Society
      2012Best in Physics Presentation, American Society for Radiation Oncology

      Professional Memberships

      PTCOG Education Committee

      2023 - Present

      ICRU Report Committee 37: Prescribing, Recording, and Reporting Proton-Beam Therapy

      2021 - Present

      AAPM Task Group 359 on FLASH (ultra-high dose rate) radiation dosimetry

      2021 - Present

      AAPM Task Group 349 on Commissioning of Monte Carlo Dose Calculation in Proton Therapy

      2020 - Present

      AAPM Medical Physics Leadership Academy Working Group

      2019 - 2025

      AAPM Work Group of Clinical Trials

      2019 - 2022

      Global Harmonization Group

      2018 - Present

      AAPM Ionization Chamber Registry Working Group

      2018 - 2021

      ASTRO Physics Core Curriculum Task Force

      2018 - 2019

      Particle Therapy Cooperative Group-North America

      2016 - Present

      American Board of Radiology

      2015 - Present

      The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences

      2015 - Present

      AAPM Brachytherapy Source Registry Work Group

      2015 - 2022

      PTCOG North America

      2014 - Present

      AAPM Work Group on Particle Beams (WGPB)

      2013 - 2024

      AAPM Task Group 224 on Proton Therapy Quality Assurance

      2012 - 2019

      American Association of Physicists in Medicine (AAPM)

      2011 - Present

      American Society for Therapeutic Radiation Oncology (ASTRO)

      2011 - Present

      Selected Presentations & Talks

      Regional Presentations

      1. 2025. Carbon ion therapy: Are we ready to saddle up?. Invited. SWAAPM. Baton Rouge, LA, US.

      National Presentations

      1. 2025. Protons and Heavy Ions. Invited. ASTRO Refresher Course, US.
      2. 2025. Proton Therapy Quality: Leveraging Peer Review Audits for Practice Improvement. Visiting. Philadelphia, Pennsylvania, US.
      3. 2025. Ensuring Quality in Proton Therapy: The Role of Peer Review Audits. Invited. Monthly Medical Physics Journal Club, US.
      4. 2025. IROC Particle Therapy Update. Invited. Particle Therapy Working Group. Phoenix, AZ, US.
      5. 2024. From Peer Review to Practice Improvement: How Photon and Proton Audits Improve Treatment Accuracy. Invited. Radiation Physics Faculty Meeting. Columbus, OH, US.
      6. 2024. IROC Particle Therapy Update. Invited. Particle Therapy Working Group. Orlando, FL, US.
      7. 2023. Development of a Carbon Ion Audit Program for Clinical Trials. Conference. Seattle, WA, US.
      8. 2023. AAPM. Conference. AAPM, VA, US.
      9. 2023. AAPM. Conference. AAPM. Houston, TX, US.
      10. 2023. AAPM CRCPD Meeting. Invited. AAPM CRCPD Meeting. Houston, TX, US.
      11. 2023. Particle Therapy Meeting and Clinical Research Nurse Meeting. Invited. Particle Therapy Meeting and Clinical Research Nurse Meeting. Orlando, FL, US.
      12. 2022. AAPM. Conference. AAPM, DC, US.
      13. 2022. Particle Therapy Peer Review. Invited. Virtual, MD, US.
      14. 2022. Particle Therapy Meeting. Invited. Particle Therapy Meeting. Virtual, US.
      15. 2021. AAPM. Conference. AAPM. Virtual, US.
      16. 2021. AAPM Spring Clinical Meeting. Conference. AAPM Spring Clinical Meeting. Virtual, US.
      17. 2020. Radiation Oncology Meeting. Invited. Radiation Oncology Meeting, US.
      18. 2020. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Houston, TX, US.
      19. 2019. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Philadelphia, PA, US.
      20. 2019. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Phoenix, AZ, US.
      21. 2018. AAPM. Conference. AAPM. Nashville, TN, US.
      22. 2018. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Philadelphia, PA, US.
      23. 2017. AAPM. Conference. AAPM. Denver, CO, US.
      24. 2017. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Philadelphia, PA, US.
      25. 2017. CIRMS Annual Meeting. Conference. CIRMS Annual Meeting. Gaithersburg, MD, US.
      26. 2017. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Houston, TX, US.
      27. 2016. PTCOG-NA. Conference. PTCOG-NA. Memphis, TN, US.
      28. 2016. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Dallas, TX, US.
      29. 2016. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Atlanta, GA, US.
      30. 2015. AAPM. Conference. AAPM. Anaheim, CA, US.
      31. 2015. Proton Therapy Meeting. Invited. Proton Therapy Meeting. San Diego, CA, US.
      32. 2014. Proton Therapy Meeting. Invited. Proton Therapy Meeting. San Diego, CA, US.
      33. 2013. AAPM. Conference. AAPM. Indianapolis, IN, US.
      34. 2013. Proton Therapy Meeting. Invited. Proton Therapy Meeting. San Diego, CA, US.
      35. 2012. ASTRO. Conference. ASTRO. Boston, MA, US.
      36. 2012. Radiation Oncology Meeting. Invited. Radiation Oncology Meeting. Atlanta, GA, US.
      37. 2012. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Philadelphia, PA, US.
      38. 2012. Clinical Proton Therapy Physics with Emphasis on Spot Scanning Beam Conference. Conference. Clinical Proton Therapy Physics with Emphasis on Spot Scanning Beam Conference. Houston, TX, US.
      39. 2011. Proton Therapy Meeting. Invited. Proton Therapy Meeting. Philadelphia, PA, US.

      International Presentations

      1. 2025. Treatment Planning Dose Calculation Algorithms. Invited. PTCOG. Buenos Aires, AR.
      2. 2025. Advancing Accuracy: A comprehensive audit program for carbon ion radiation therapy. Conference. ESTRO. Vienna, AT.
      3. 2025. Ensuring Quality in Proton Therapy: The Role of Peer Review Audits. Invited. McGill Medical Physics Friday Noon Seminar Series, US.
      4. 2024. Treatment Planning Dose Calculation Algorithms. Invited. PTCOG Education Session. Signapore, SG.
      5. 2024. Maintaining a national audit service for evolving radiotherapy technologies. Invited. Melbourne, AU.
      6. 2024. From Peer Review to Practice Improvement: How Photon and Proton Audits Improve Treatment Accuracy. Invited. Virtual Medical Physics Conference. Taipei, TW.
      7. 2023. Particle Therapy Peer Review. Invited. Faculty of Science Institute of Medical Physics. Sydney, AU.
      8. 2023. ESTRO. Conference. ESTRO. Vienna.
      9. 2022. PTCOG. Conference. PTCOG. Miami, US.
      10. 2019. IDOS. Conference. IDOS. Vienna, AT.
      11. 2019. PTCOG. Conference. PTCOG. Manchester, GB.
      12. 2015. PTCOG. Conference. PTCOG. San Diego, US.

      Formal Peers

      1. 2023. Evolution of proton therapy in clinical trials and audits. Invited, US.
      2. 2022. “Particle Therapy Peer Review. Invited, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2025 - 2026
      Title:FLASH proton therapy: an innovative ultra-fast and ultra-sharp scalpel for radiosurgery
      Funding Source:MD Anderson
      Role:Co-I
      ID:2025-00064784-Y1
      Date: 2019 - 2025
      Title:Imaging and Radiation Oncology Core (IROC) Group
      Funding Source:American College of Radiology
      Role:Co-I
      ID:CA180803

      Selected Publications

      Peer-Reviewed Articles

      1. Kry, SF, Molineu, HA, Alvarez, PE, Glenn, MC, Leif, JL, Hernandez, N, Nguyen, T, Taylor, PA. Dose delivery accuracy of advanced radiotherapy. Radiotherapy and Oncology 223, 2026. e-Pub 2026. PMID: 42320678.
      2. Gearhardt, AG, Pollard-Larkin, JM, Peeler, CR, Taylor, PA, Shete, S, Best, C, Kry, SF. Current Practice for Electronic Medical Device Management in Radiation Therapy. Clinical Oncology 56, 2026. e-Pub 2026. PMID: 42413313.
      3. Guan, F, Tang, J, Brookner, A, Scott, H, Vazquez, I, Campelo, S, Liu, D, Mathew, J, Bronk, LF, Li, Y, Taylor, PA. Lighting up FLASH and beyond. Medical physics 53(8), 2026. e-Pub 2026. PMID: 42525493.
      4. Charyyev, S, Maradia, V, Chang, CW, Lin, L, Dong, L, Li, H, Schuemann, J, Shen, J, Kang, M, Taylor, PA, Zhang, Y, Tang, S, Wang, P, Freund, D, Zhang, H, Zhao, T, Chang, C, Chen, CC, Pankuch, M, Gao, M, Yu, F, Lin, H, Li, Z, Wong, T, Regmi, R, Poels, K, Depuydt, T, Liu, H, Broekhoven, BL, Mossahebi, S, Yi, BY, Paxton, AB, Matsuura, T, Wang, Z, Vilches-Freixas, G, Lin, Y, Kurucz, S, Ding, X. Multiinstitutional survey of source modeling parameters for proton pencil beam scanning treatment planning system commissioning. Medical physics 52(12), 2025. e-Pub 2025. PMID: 41389057.
      5. Chang, CC, Selvaraj, B, Zhao, X, Rembish, J, Taylor, PA, Bookbinder, A, Cheng, C, Choi, JI, Simone, C, Lin, H, Kang, M. First experience with third-party validations. Journal of applied clinical medical physics 26(10), 2025. e-Pub 2025. PMID: 41014172.
      6. Hartzell, S, Taddei, PJ, Guan, F, Mirandola, A, Taylor, PA, Ciocca, M, Magro, G, Peterson, CB, Kry, SF. Microdosimetric evaluation of a clinical carbon ion beam using a tissue-equivalent proportional counter. Physics in medicine and biology 70(14), 2025. e-Pub 2025. PMID: 40602421.
      7. Kang, M, Taylor, PA, Shen, J, Zhou, J, Saini, J, Hong, TS, Higgins, K, Liu, W, Xiao, Y, Simone, C, Lin, L. NRG Oncology Liver Proton SBRT and Hypofractionated Radiation Therapy. Cancers 17(14), 2025. e-Pub 2025. PMID: 40723252.
      8. Hartzell, S, Guan, F, Magro, G, Taylor, PA, Peterson, CB, Kry, SF. Quantifying Sensitivity of Carbon RBE Models to Reference Parameter Variations. Radiation research 204(2):113-126, 2025. e-Pub 2025. PMID: 40451240.
      9. Taylor PA, Mirandola A, Ciocca M, Hartzell S, Magro G, Alvarez P, Peterson CB, Peeler CR, Koay EJ, Howell RM, Kry SF. Characterization of LiF TLD-100 in carbon ion beams for remote audits. Med Phys 52(3):1858-1866, 2025. e-Pub 2025. PMID: 39718203.
      10. Hartzell, S, Guan, F, Magro, G, Taylor, PA, Taddei, PJ, Peterson, CB, Kry, SF. Contribution of Nuclear Fragmentation to Dose and RBE in Carbon-Ion Radiotherapy. Radiation research 203(2):96-106, 2025. e-Pub 2025. PMID: 39862066.
      11. Taylor, PA, Mirandola, A, Ciocca, M, Hartzell, S, Vai, A, Alvarez, PE, Howell, RM, Koay, EJ, Peeler, CR, Peterson, CB, Kry, SF. Technical note. Medical physics 51(7):5154-5158, 2024. e-Pub 2024. PMID: 38598230.
      12. Taylor PA, Hartzell S, Mirandola A, Ciocca M, Magro G, Alvarez P, Peterson CB, Peeler CR, Koay EJ, Howell RM, Kry SF. OSLD nanoDot characterization for carbon radiotherapy dosimetry. Phys Med Biol 69(11), 2024. e-Pub 2024. PMID: 38663410.
      13. Faddegon B, Descovich M, Chen K, Ramos-Méndez J, Iii MR, Wahl N, Taylor P, Griffin K, Lee C. A digital male pelvis phantom series showing anatomical variations over the course of fractionated radiotherapy treatment. Med Phys 51(4):3034-3044, 2024. e-Pub 2023. PMID: 38071746.
      14. Shen, J, Taylor, PA, Vargas, C, Kang, M, Saini, J, Zhou, J, Wang, P, Liu, W, Simone, C, Xiao, Y, Lin, L. The Status and Challenges for Prostate Stereotactic Body Radiation Therapy Treatments in United States Proton Therapy Centers. International Journal of Particle Therapy 11, 2024. e-Pub 2024. PMID: 38757080.
      15. Zou W, Zhang R, Schüler E, Taylor PA, Mascia AE, Diffenderfer ES, Zhao T, Ayan AS, Sharma M, Yu SJ, Lu W, Bosch WR, Tsien C, Surucu M, Pollard-Larkin JM, Schuemann J, Moros EG, Bazalova-Carter M, Gladstone DJ, Li H, Simone CB, Petersson K, Kry SF, Maity A, Loo BW, Dong L, Maxim PG, Xiao Y, Buchsbaum JC. Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps. Int J Radiat Oncol Biol Phys 116(5):1202-1217, 2023. e-Pub 2023. PMID: 37121362.
      16. Taylor PA, Miles E, Hoffmann L, Kelly SM, Kry SF, Sloth Møller D, Palmans H, Akbarov K, Aznar MC, Clementel E, Corning C, Effeney R, Healy B, Moore A, Nakamura M, Patel S, Shaw M, Stock M, Lehmann J, Clark CH. Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison. Radiother Oncol 182:109494, 2023. e-Pub 2023. PMID: 36708923.
      17. Taylor, P A, Miles, E, Hoffmann, L, Kelly, S M, Kry, S F, Møller S, D, Palmans, H, Akbarov, K, Aznar, M C, Clementel, E, Corning, C, Effeney, R, Healy, B, Moore, A, Nakamura, M, Patel, S, Shaw, M, Stock, M, Lehmann, J, Clark, C H. Prioritizing clinical trial quality assurance for photon and protons: A failure modes and effect analysis (FMEA) comparison. Radiotherapy and Oncology 182(109494), 2023. e-Pub 2023.
      18. Mehrens H, Taylor P, Alvarez P, Kry S. Analysis of Performance and Failure Modes of the IROC Proton Liver Phantom. Int J Part Ther 10(1):23-31, 2023. e-Pub 2023. PMID: 37823015.
      19. Zhu XR, Li Y, Yang M, Whitaker TJ, Taylor PA, Zhang X, Poenisch F, Sahoo N, Liao Z, Chang JY. Stereotactic body proton therapy for early stage non-small cell lung cancer - Technical challenges and solutions: The MD Anderson experience. J Radiosurg SBRT 9(1):75-82, 2023. e-Pub 2023. PMID: 38029015.
      20. Maroongroge S, Pinnix CC, Wallington DG, Taylor PA, Zhu D, Guadagnolo BA, Smith BD, Yu JB, Ballas LK. In Reply to Smith et al. Int J Radiat Oncol Biol Phys 113(3):696-697, 2022. e-Pub 2022. PMID: 35777400.
      21. Maroongroge S, Wallington DG, Taylor PA, Zhu D, Guadagnolo BA, Smith BD, Yu JB, Ballas LK. Geographic access to radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys 112(3):600-610, 2022. e-Pub 2022. PMID: 34762972.
      22. Taylor PA, Lowenstein J, Followill D, Kry SF. The Value of On-Site Proton Audits. Int J Radiat Oncol Biol Phys 112(4):1004-1011, 2022. e-Pub 2022. PMID: 34780973.
      23. Mehrens H, Nguyen T, Edward S, Hartzell S, Glenn M, Branco D, Hernandez N, Alvarez P, Molineu A, Taylor P, Kry S. The current status and shortcomings of stereotactic radiosurgery. Neurooncol Adv 4(1):vdac058, 2022. e-Pub 2022. PMID: 35664554.
      24. Hartzell S, Guan F, Taylor P, Peterson C, Taddei P, Kry S. Uncertainty in tissue equivalent proportional counter assessments of microdosimetry and RBE estimates in carbon radiotherapy. Phys Med Biol 66(15), 2021. e-Pub 2021. PMID: 34252894.
      25. Taylor PA, Alvarez PE, Mehrens H, Followill DS. Failure modes in IROC photon liver phantom irradiations. Pract Radiat Oncol 11(3):e322-e328, 2021. e-Pub 2020. PMID: 33271351.
      26. Branco D, Kry S, Taylor P, Zhang X, Rong J, Frank S, Followill D. Dosimetric impact of commercial CT metal artifact reduction algorithms and a novel in-house algorithm for proton therapy of head and neck cancer. Med Phys 48(1):445-455, 2021. e-Pub 2020. PMID: 33176003.
      27. Branco D, Kry S, Taylor P, Rong J, Zhang X, Frank S, Followill D. Evaluation of image quality of a novel computed tomography metal artifact management technique on an anthropomorphic head and neck phantom. Phys Imaging Radiat Oncol 17:111-116, 2021. e-Pub 2021. PMID: 33898789.
      28. Lin L, Taylor PA, Shen J, Saini J, Kang M, Simone CB, Bradley JD, Li Z, Xiao Y. NRG oncology survey of monte carlo dose calculation use in US proton therapy centers. Int J Part Ther 8(2):73-81, 2021. e-Pub 2021. PMID: 34722813.
      29. Hua CH, Vern-Gross TZ, Hess CB, Olch AJ, Alaei P, Sathiaseelan V, Deng J, Ulin K, Laurie F, Gopalakrishnan M, Esiashvili N, Wolden SL, Krasin MJ, Merchant TE, Donaldson SS, FitzGerald TJ, Constine LS, Hodgson DC, Haas-Kogan DA, Mahajan A, Laack NN, Marcus KJ, Taylor PA, Ahern VA, Followill DS, Buchsbaum JC, Breneman JC, Kalapurakal JA. Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report. Pediatr Blood Cancer:e28629. e-Pub 2020. PMID: 32776500.
      30. Branco D, Kry S, Taylor P, Rong J, Zhang X, Peterson C, Frank S, Followill D. Development of a stereoscopic CT metal artifact management algorithm using gantry angle tilts for head and neck patients. J Appl Clin Med Phys. e-Pub 2020. PMID: 32506820.
      31. Edward SS, Alvarez PE, Taylor PA, Molineu HA, Peterson CB, Followill DS, Kry SF. Differences in the patterns of failure between IROC lung and spine phantom irradiations. Pract Radiat Oncol. e-Pub 2020. PMID: 32413413.
      32. Mehrens H, Taylor P, Followill DS, Kry SF. Survey results of 3D-CRT and IMRT quality assurance practice. J Appl Clin Med Phys. e-Pub 2020. PMID: 32351006.
      33. Arjomandy B, Taylor P, Ainsley C, Safai S, Sahoo N, Pankuch M, Farr JB, Yong Park S, Klein E, Flanz J, Yorke ED, Followill D, Kase Y. AAPM task group 224: Comprehensive proton therapy machine quality assurance. Med Phys 46(8):e678-e705, 2019. e-Pub 2019. PMID: 31125441.
      34. Kang Y, Shen J, Liu W, Taylor PA, Mehrens HS, Ding X, Hu Y, Tryggestad E, Keole SR, Schild SE, Wong WW, Fatyga M, Bues M. Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons. Radiat Oncol 14(1):108, 2019. e-Pub 2019. PMID: 31208439.
      35. Wang P, Tang S, Taylor PA, Cummings DE, Janson M, Traneus E, Sturgeon JD, Lee AK, Chang C. Clinical examination of proton pencil beam scanning on a moving anthropomorphic lung phantom. Med Dosim 44(2):122-129, 2019. e-Pub 2019. PMID: 29759487.
      36. Huang S, Souris K, Li S, Kang M, Barragan Montero AM, Janssens G, Lin A, Garver E, Ainsley C, Taylor P, Xiao Y, Lin L. Validation and application of a fast Monte Carlo algorithm for assessing the clinical impact of approximations in analytical dose calculations for pencil beam scanning proton therapy. Med Phys 45(12):5631-5642, 2018. e-Pub 2018. PMID: 30295950.
      37. Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Kry SF. Reference dosimetry data and modeling challenges for Elekta accelerators based on IROC-Houston site visit data. Med Phys 45(5):2337-2344, 2018. e-Pub 2018. PMID: 29537634.
      38. Branco D, Taylor P, Zhang H, Li H, Guindani M, Followill D. An anthropomorphic head and neck quality assurance phantom for credentialing of intensity-modulated proton therapy. International Journal of Particle Therapy, 2018. e-Pub 2018.
      39. Lewis DJ, Taylor PA, Followill DS, Sahoo N, Mahajan A, Stingo FC, Kry SF. A new anthropomorphic pediatric spine phantom for proton therapy clinical trial credentialing. Int J Part Ther 4(4):20-27, 2018. e-Pub 2018. PMID: 30214913.
      40. Kry SF, Dromgoole L, Alvarez P, Leif J, Molineu A, Taylor P, Followill DS. Radiation therapy deficiencies identified during on-site dosimetry visits by the Imaging and Radiation Oncology Core Houston Quality Assurance Center. Int J Radiat Oncol Biol Phys 99(5):1094-1100, 2017. e-Pub 2017. PMID: 29029890.
      41. Taylor PA, Kry SF, Followill DS. Pencil beam algorithms are unsuitable for proton dose calculations in lung. Int J Radiat Oncol Biol Phys 99(3):750-756, 2017. e-Pub 2017. PMID: 28843371.
      42. Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Kry SF. Agreement between institutional measurements and treatment planning system calculations for basic dosimetric parameters as measured by the Imaging and Radiation Oncology Core-Houston. Int J Radiat Oncol Biol Phys 95(5):1527-1534, 2016. e-Pub 2016. PMID: 27315667.
      43. Martin MT, Telebak E, Taylor PA, Volozhina O. Development of a specialty medication prior-authorization service at an urban academic medical center. Am J Health Syst Pharm 73(15):1174-1179, 2016. e-Pub 2016. PMID: 27440624.
      44. Taylor PA, Kry SF, Alvarez P, Keith T, Lujano C, Hernandez N, Followill DS. Results from the Imaging and Radiation Oncology Core Houston's anthropomorphic phantoms used for proton therapy clinical trial credentialing. Int J Radiat Oncol Biol Phys 95(1):242-248, 2016. e-Pub 2016. PMID: 27084644.
      45. Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Stingo FC, Kry SF. Technical Report: Reference photon dosimetry data for Varian accelerators based on IROC-Houston site visit data. Med Phys 43(5):2374, 2016. e-Pub 2016. PMID: 27147349.
      46. Cho J, Summers PA, Ibbott GS. An anthropomorphic spine phantom for proton beam approval in NCI-funded trials. J Appl Clin Med Phys 15(3):252-265, 2014. e-Pub 2014. PMID: 24892351.
      47. Grant RL, Summers PA, Neihart JL, Blatnica AP, Sahoo N, Gillin MT, Followill DS, Ibbott GS. Relative stopping power measurements to aid in the design of anthropomorphic phantoms for proton radiotherapy. J Appl Clin Med Phys 15(2):4523, 2014. e-Pub 2014. PMID: 24710437.
      48. Moyers MF, Ibbott GS, Grant RL, Summers PA, Followill DS. Independent dose per monitor unit review of eight U.S.A. proton treatment facilities. Med Phys 41(1):012103-01 - 012103-5, 2014. e-Pub 2014. PMID: 24387521.
      49. Iqbal K, Gillin M, Summers PA, Dhanesar S, Gifford KA, Buzdar SA. Quality assurance evaluation of spot scanning beam proton therapy with an anthropomorphic prostate phantom. Br J Radiol 86(1031):20130390, 2013. e-Pub 2013. PMID: 24049129.
      50. Dhanesar S, Sahoo N, Kerr M, Taylor MB, Summers P, Zhu XR, Poenisch F, Gillin M. Quality assurance of proton beams using a multilayer ionization chamber system. Med Phys 40(9):092102-1 - 092102-9, 2013. e-Pub 2013. PMID: 24007171.
      51. Tanyi JA, He T, Summers PA, Mburu RG, Kato CM, Rhodes SM, Hung AY, Fuss M. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: Role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys 5(78):1579-1585, 2010. e-Pub 2010. PMID: 20472357.

      Review Articles

      1. Xiao, Y, Benedict, SH, Cui, Y, Glide-Hurst, CK, Graves, S, Jia, X, Kry, SF, Li, H, Lin, L, Matuszak, MM, Newpower, M, Paganetti, H, Qi, XS, Roncali, E, Rong, Y, Sgouros, G, Simone, C, Sunderland, J, Taylor, PA, Tchelebi, LT, Weldon, M, Zou, JW, Wuthrick, EJ, Machtay, M, Le, QT, Buchsbaum, J. Embracing the Future of Clinical Trials in Radiation Therapy. International Journal of Radiation Oncology Biology Physics 122(2):443-457, 2025. e-Pub 2025. PMID: 39848295.
      2. Paganetti, H, Simone, C, Bosch, WR, Haas-Kogan, D, Kirsch, DG, Li, H, Liang, X, Liu, W, Mahajan, A, Story, MD, Taylor, PA, Willers, H, Xiao, Y, Buchsbaum, J. NRG Oncology White Paper on the Relative Biological Effectiveness in Proton Therapy. International Journal of Radiation Oncology Biology Physics 121(1):202-217, 2025. e-Pub 2025. PMID: 39059509.
      3. Liu, W, Feng, H, Taylor, PA, Kang, M, Shen, J, Saini, J, Zhou, J, Giap, H, Yu, NY, Sio, TS, Mohindra, P, Chang, JY, Bradley, JD, Xiao, Y, Simone, C, Lin, L. NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies. International Journal of Radiation Oncology Biology Physics 119(4):1208-1221, 2024. e-Pub 2024. PMID: 38395086.
      4. Taylor PA, Moran JM, Jaffray DA, Buchsbaum JC. A roadmap to clinical trials for FLASH. Med Phys 49(6):4099-4108, 2022. e-Pub 2022. PMID: 35366339.
      5. Kry SF, Lye J, Clark CH, Andratschke N, Dimitriadis A, Followill D, Howell R, Hussein M, Ishikawa M, Kito S, Kron T, Lee J, Michalski J, Filippo Monti A, Reynaert N, Taylor P, Venables K, Xiao Y, Lehmann J. Report dose-to-medium in clinical trials where available; a consensus from the global Harmonisation group to maximize consistency. Radiother Oncol 159:106-111, 2021. e-Pub 2021. PMID: 33741471.
      6. Yock AD, Mohan R, Flampouri S, Bosch W, Taylor PA, Gladstone D, Kim S, Sohn J, Wallace R, Xiao Y, Buchsbaum J. Robustness analysis for external beam radiation therapy treatment plans: describing uncertainty scenarios and reporting their dosimetric consequences. Pract Radiat Oncol 9(4):200-207, 2019. e-Pub 2019. PMID: 30562614.

      Other Articles

      1. Xiao, Y, Benedict, SH, Cui, Y, Glide-Hurst, CK, Graves, S, Jia, X, Kry, SF, Li, H, Lin, L, Matuszak, MM, Newpower, M, Paganetti, H, Qi, XS, Roncali, E, Rong, Y, Sgouros, G, Simone, C, Sunderland, J, Taylor, PA, Tchelebi, LT, Weldon, M, Zou, JW, Wuthrick, EJ, Machtay, M, Le, QT, Buchsbaum, J Erratum to Xiao Y, Benedict S, Cui Y, Glide-Hurst C, Graves S, Jia X, KryF S, Li H, Lin L, Matuszak M, Newpower M, Paganetti H, Qi XS, Roncali E, Rong Y, Sgouros G, Simone 2nd CB, Sunderland JJ, Taylor PA, Tchelebi L, Weldon M, Zou JW, Wuthrick EJ, Machtay M, Le QT, Buchsbaum JC. Embracing the future of clinical trials in radiation therapy. International Journal of Radiation Oncology Biology Physics 124(2):560, 2026. PMID: 41545103.

      Editorials

      1. Garibaldi, C, Beddar, S, Bizzocchi, N, Tobias Böhlen, T, Iliaskou, C, Moeckli, R, Psoroulas, S, Subiel, A, Taylor, PA, Van den Heuvel, F, Vanreusel, V, Verellen, D. Minimum and optimal requirements for a safe clinical implementation of ultra-high dose rate radiotherapy. Radiotherapy and Oncology 196, 2024. PMID: 38648991.

      Abstracts

      1. Liu D, Tang J, Mathew J, Ellison D, Campelo S, Wang X, Zlateva Y, Briere T, Pollard-Larkin J, Bronk L, Taylor PA, Li Y, Guan F. Dose Rate and Microdosimetric Effects on Radiochromic Film Response to Synchrotron-Based Proton Irradiation. American Society for Radiation Oncology. e-Pub 2026.
      2. Guan F, Campelo S, Li Y, Taylor P, Bronk L, Zlateva Y, Grosshans D, Koong A, Li J, Mohan R, Kry S, Sahoo N, Briere T. Novel Accelerator-Based Boron Neutron Capture Therapy Approach for Brain Tumor Treatment Leveraging Existing Proton Therapy Infrastructure. e-Pub 2025.
      3. Mathew J, Liu D, Tang J, Grosshans D, Taylor P, Li Y, Bronk L, Guan F. Characterization of DNA Damage Patterns in Cancer Cells Following Particle Radiation using Immunofluorescent Foci Analysis. Division of Radiation Oncology Summer Student Symposium, 2025. e-Pub 2025.
      4. Liu D, Tang J, Mathew J, Wang X, Zlateva Y, Briere T, Bronk L, Taylor P, Li Y, Guan F. Dose Rate and Microdosimetric Effects on Gafchromic Film Response to Synchrotron-Based Proton Irradiation, 2025. e-Pub 2025.
      5. Mathew J, Liu D, Tang J, Grosshans D, Li Y, Taylor P, Guan F, Bronk L. 53BP1 Foci Analysis Reveals Linear Energy Transfer-Dependent DNA Repair Patterns Correlating with Relative Biological Effectiveness of Therapeutic Protons, 2025. e-Pub 2025.
      6. Liu D, Tang J, Mathew J, Wang X, Zlateva Y, Briere T, Bronk L, Taylor P, Li Y, Guan F. Characterizing Gafchromic EBT4 Film Performance for Synchrotron Proton Dosimetry: Dose Rate and Radiation Quality Effects, 2025. e-Pub 2025.
      7. Tang J, Liu D, Mathew J, Scott H, Hu Z, Titt U, Mohan R, Bronk L, Li Y, Taylor P, Guan F. Experimental Design and Control Methods for Dose Rate Optimization in Proton Therapy, 2025. e-Pub 2025.
      8. Branco D, Kry S, Taylor P, Zhang X, Rong J, Frank S, Followill D. Image quality of commercial CT metal artifact reduction algorithms and a novel in-house algorithm for head and neck (H&N) cancer and the dosimetric implications on proton therapy. Med Phys. e-Pub 2020.
      9. Edward S, Kry S, Followill D, Peterson C, Molineu A, Taylor P, Alvarez P. Institutional performance on IROC phantom as a function of phantom type: a multi-variate analysis. Med Phys. e-Pub 2020.
      10. Followill D, Lowenstein J, Molineu A, Alvarez P, Taylor P, Kry S. The IROC Houston Quality Assurance Center’s independent peer review QA program. Med Phys. e-Pub 2020.
      11. Hartzell S, Guan F, Vassiliev O, Taylor P, Peterson C, Kry S. Assessment of Microdosimetric measurement uncertainty in carbon ion radiotherapy. Med Phys. e-Pub 2020.
      12. Hartzell S, Guan F, Vassiliev O, Taylor P, Peterson C, Kry S. Microdosimetric assessment of model based relative biological effectiveness in carbon ion therapy. Med Phys. e-Pub 2020.
      13. Mehrens H, Nguyen T, Glenn M, Branco D, Edward S, Hartzell S, Hernandez N, Alvarez P, Molineu A, Taylor P, Followill D, Kry S. Evaluation of trends and performance indicatiors for IROC Houston's SRS head phantom. Med Phys. e-Pub 2020.
      14. Quirk S, Ritter T, Ebert M, Smith W, Taylor P, Sohn J, Matuszak M. Investigation of variability and standardization in normal tissue dose limits across multi-institutional clinical trials. Med Phys. e-Pub 2020.
      15. Alvarez P, Taylor P, Lowenstein J, Molineu A, Kry S, Followill D. New acceptance criteria for evaluating electron beam percentage depth dose using OSLD remote audits. Med Phys. e-Pub 2019.
      16. Taylor P, Alvarez P, Mehrens H, Followill D. Results of IROC anthropomorphic liver phantom irradiation with protons and photons. Med Phys. e-Pub 2019.
      17. Edward S, Alvarez P, Taylor P, Molineu A, Followill D, Kry S. Differences in patterns of failure between the Imaging and Radiation Oncology Core (IROC) lung and spine phantom irradiation. Med Phys. e-Pub 2019.
      18. Luckett B, Alvarez P, Taylor P, Kry S, Peterson C, Luo D, Followill D. Commissioning of TLD micro-cubes for a remote SRS audit program. Med Phys. e-Pub 2019.
      19. Hartzell S, Guan F, Vassiliev O, Peterson C, Taylor P, Kry S. Introducing uncertainty to measurements based RBE assessment in carbon ion radiotherapy. e-Pub 2019.
      20. Branco D, Taylor P, Kry S, Zhang X, Rong J, Frank S, Followill D. An innovative artifact management method for proton therapy planning (AMPP) of the head and neck. Med Phys. e-Pub 2019.
      21. Followill D, Lowenstein J, Taylor P, Molineu A, Alvarez P, Ibbott G, Hanson W, Kry S. The 50th anniversary of the Radiological Physics Center/IROC Houston QA Center activities and findings. Med Phys. e-Pub 2018.
      22. Branco D, Taylor P, Kry S, Mirkovic D, Followill D. Evaluation of proton therapy dose calculations in a simple geometrical static lung phantom. Med Phys. e-Pub 2018.
      23. Taylor P, Branco D, Hernandez N, Followill D. A pilot study of IROC's proton head & neck phantom. Med Phys. e-Pub 2018.
      24. Alvarez P, Molineu A, Taylor P, Nguyen T, Mehrens H, Pajot N, Followill D. Can we change the acceptance criteria for the IROC lung phantom used for credentialing purposes?. Med Phys. e-Pub 2018.
      25. Taylor P, Mehrens H, Alvarez P, Followill D. Evaluation criteria for IROC's proton prostate phantom. Med Phys. e-Pub 2018.
      26. Followill D, Molineu A, Alvarez P, Lowenstein J, Taylor P, Hernandez N, Nguyen T, Mehrens H, Lewis B, Kry, S. IROC Houston QA Center end-to-end QA phantom program key findings over the past 15 years. e-Pub 2017.
      27. Alvarez P, Molineu A, Lowenstein J, Taylor P, Kry S, Followill D. IROC Houston QA Center's independent peer review quality assurance program for the Veteran Affairs VA radiotherapy facilities. e-Pub 2017.
      28. Taylor P, Kry S, Followill D. Monte Carlo shows large improvement over analytic algorithms in calculating proton therapy dose to thoracic tumors in IROC lung phantom. e-Pub 2017.
      29. Carson ME, Molineu A, Taylor PA, Followill DS, Stingo FC, Kry SF. Examining credentialing criteria and poor performance indicators for IROC Houston's anthropomorphic head and neck phantom. Med Phys 43(12):3841, 2016. e-Pub 2016. PMID: 27908168.
      30. Alvarez P, Molineu A, Lowenstein J, Taylor P, Kry S, Followill D. Independent remote audits for TG-51 non-compliant photon beams performed by the IROC Houston QA Center. Med Phys 43(6):3574. e-Pub 2016.
      31. Branco D, Taylor P, Zhang X, Li H, Guidani M, Mehrens H, Followill D. Development and implementation of an anthopomorphic head and neck phantom for the assessment of proton therapy treatment procedures 43(6):3500. e-Pub 2016.
      32. Taylor P, Craft D, Followill D, Howell R. Proton therapy tissue-equivalence of 3D printed materials 43(6):3500. e-Pub 2016.
      33. Lee P, Alvarez P, Taylor P, Lowenstein J, Molineu A, Kry S, Followill D. An analysis of TG-51 electron beam calibration correction factor uncertainty. Med Phys 42(6):3353-3354, 2015. e-Pub 2015.
      34. Arjomandy B, Klein E, Taylor P, Ainsley C, Safai S, Sahoo N, Pankuch M, Park S, Farr J, Kase Y, Flanz J, Yorke E, Followill D. Quality assurances for proton therapy delivery equipment. Med Phys 42(6):3485-3486, 2015. e-Pub 2015.
      35. McInnis M, Taylor P, Poenisch F, Court L, Guindani M, Followill D. Uncertainties in treatment planning for IROC-Houston proton phantom QA program due to variable CT technique and proton energy. Med Phys 42(6):3515, 2015. e-Pub 2015.
      36. Lujano C, Hernandez N, Keith T, Nguyen T, Taylor P. IROC Houston QA Center's anthropomorphic proton phantom program. Med Phys 42(6):3580-3581, 2015. e-Pub 2015.
      37. Taylor P, Lowenstein J, Kry S, Ibbott G, Followill D. A comparison of CT number to relative linear stopping power conversion curves used by proton therapy centers. Med Phys 42(6):3616, 2015. e-Pub 2015.
      38. Schulte R, Choy H, P T, Lee C. Clinical trials in proton and particle therapy. Med Phys 42(6):3629, 2015. e-Pub 2015.
      39. Taylor P. IROC Houston's proton beam validation for clinical trials. Med Phys 42(6):3629, 2015. e-Pub 2015.
      40. Followill D, Kry S, Molineu A, Lowenstein J, Alvarez P, Taylor P, Nguyen H, Hernandez N, Lujano C, Nguyen T, Keith T, Roll J, Tailor A. The Imaging and Radiation Oncology Core Houston (IROC Houston) QA Center international activities outside North America. Med Phys 42(6):3628, 2015. e-Pub 2015.
      41. Kry S, Dromgoole L, Alvarez P, Lowenstein J, Molineu A, Taylor P, Followill D. Common errors and deficiencies in radiation oncology practice. Med Phys 42(6):3691-3692, 2015. e-Pub 2015.
      42. Kry S, Dromgoole L, Alvarez P, Lowenstein J, Molineu A, Taylor P, Followill D. IROC Houston on-site audits and parameters that affect performance. Med Phys 42(6):3692, 2015. e-Pub 2015.
      43. Sloboda R, Ballester F, Tedgren Carlsson A, Culberson W, Esthappan J, Haworth A, Lowenstein J, Ma Y, Mourtada F, Papagiannis P, Pike T, Rivard M, Siebert F, Smith R, Spadinger I, Taylor P, Verhaegen F, Vijande J, Beaulieu L. Infrastructure and process for model-based dose calculation software commissioning in brachytherapy. Med Phys 42(6):3708, 2015. e-Pub 2015.
      44. Taylor P, Lowenstein J, Ibbott G, Alvarez A, Kry S, Molineu A, Followill D. A summary of findings from the IROC Houston proton therapy audit program. International Journal of Particle Therapy 2(1), 2015. e-Pub 2015.
      45. Followill DS, Lowenstein J, Molineu A, Alvarez P, Summers P, Kry S. The Radiological Physics Center (RPC): 45 years of improving radiotherapy dosimetry. Med Phys 41(6). e-Pub 2014.
      46. Lewis D, Summers P, Followill D, Sahoo N, Mahajan A, Stingo F, Kry S. Development of implementation of an anthropomorphic pediatric spine phantom for the assessment of craniospinal irradiation procedures in proton therapy. Med Phys 41(6). e-Pub 2014.
      47. Stoker J, Summers P, Li X, Gomez D, Sahoo N, Zhu X, Gillin M. Dosimetric impact of scan orientation relative to target motion during spot scanning proton therapy. Med Phys 41(6). e-Pub 2014.
      48. Kerns J, Alvarez P, Followill DS, Lowenstein J, Molineu A, Summers P, Kry S. Small field jaw/MLC reference data. Med Phys 41(6). e-Pub 2014.
      49. Summers P, Lowenstein J, Jakel O, Prokesch H, Alvarez P, Followill DS. Validation of the use of OSLD for carbon beam remote dosimetry. Med Phys 41(6). e-Pub 2014.
      50. Kerns J, Alvarez P, Followill D, Lowenstein J, Molineu A, Summers P, Kry S. Aggregation of linac measurement data. Med Phys 41(6). e-Pub 2014.
      51. Summers PA, Ibbott GS, Alvarez P, Moyers M, Lafratta R, Followill DS. Compilation of proton therapy data from the approval process for NCI-funded clinical trials. Int J Radiat Oncol Biol Phys 90(1), 2014. e-Pub 2014.
      52. Neihart J, Sahoo N, Balter P, Summers P, Palmer M, Kerr M, Followill D. Design and verification of a heterogeneous proton equivalent thorax phantom for use in end to end assessment of pencil beam proton therapy. Med Phys 40(6):297, 2013. e-Pub 2013.
      53. Dhanesar S, Sahoo N, Kerr M, Taylor M, Summers P, Alvarez P, Wu R, Poenisch F, Zhu X, Gillin M. Intensity modulated proton therapy plans with multiple fields for prostate cancer. Med Phys 40(6):422, 2013. e-Pub 2013.
      54. Summers P, Ibbott G, Moyers M, Grant R, Followill D. Radiological Physics Center (RPC) approval of proton centers for NCI-sponsored clinical trials. Med Phys 40(6):548, 2013. e-Pub 2013.
      55. Summers P. Comparison of clinical parameters for proton therapy in the United States. Int J Radiat Oncol Biol Phys, 2012. e-Pub 2012.
      56. Summers P. Comparison of proton therapy institutional ata. Med Phys, 2012. e-Pub 2012.
      57. Summers P. The RPC proton therapy approval process. Med Phys, 2012. e-Pub 2012.
      58. Followill D, Lowenstein J, Molineu A, Alvarez P, Aguirre J, Kry S, Summers P, Ibbott G. The Radiological Physics Center's quality audit program. Med Phys 6(39):3866, 2012. e-Pub 2012.
      59. Tonigan J, Kry S, Summers P, Balter P, Diel T, Followill D. The magnitude of head & neck IMRT dose delivery errors from three possible failure modes. Med Phys 39(6):3999, 2012. e-Pub 2012.
      60. Lowenstein J, Kry S, Molineu A, Alvarez P, Aguirre J, Summers P, Followill D. High-energy photon standard dosimetry data. Med Phys 6(39):3754, 2012. e-Pub 2012.
      61. Song X, Sahoo N, Wu R, Taylor M, Georges R, Zhu X, Summers P, Gillin M. Dosimetry of double scattered proton beam fields used for cranio-spinal irradiation. Med Phys 6(39):3770, 2012. e-Pub 2012.
      62. Dhanesar S, Sahoo N, Taylor M, Song X, Poenisch F, Summers P, Li H, Zhu XR, Gillin M. Evaluation of Zebra multi-layer ionization chamber system for patient treatment field and machine QA for spot scanning and passive scattering proton beams. Med Phys 6(39):3613, 2012. e-Pub 2012.
      63. Summers P, Followill D, Sahoo N, Poenisch F, Tucker S, Gillin M, Riley B, Ibbott G. Development of an anthropomorphic head phantom for the assessment of proton therapy treatment procedures. Med Phys, 2011. e-Pub 2011.

      Book Chapters

      1. Taylor PA. Credentialing Proton Centers for Clinical Trials. In: Proton Therapy - Current Status and Future Directions. IntechOpen, 2021.
      2. Taylor PA. Clinical Trials Evaluating Proton Therapy. In: Proton Therapy - Current Status and Future Directions. IntechOpen, 2021.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 04, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top